Uniplan Investment Counsel, Inc.

Position in RPRX — Royalty Pharma plc

CIK 1520710 MILWAUKEE, WI

Position in RPRX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,256,761

+$711,696 QoQ

Shares Held

88,738

-3.3% QoQ

Ownership

0.015%

of shares outstanding

% of Portfolio

0.47%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2024

6 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Uniplan Investment Counsel, Inc. holds $19,321,657 across 4 Biotechnology names. RPRX ranks #3 (22.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LGND	Ligand Pharmaceuticals Inc	40,185	$8,022,935
2	INVA	Innoviva, Inc.	229,338	$5,343,575
3	RPRX	Royalty Pharma plc This page	88,738	$4,256,761
4	AUPH	Aurinia Pharmaceuticals Inc.	114,601	$1,698,386

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,256,761	88,738	-3.3%	Shares	Sole	2026-05-15
2025-12-31	$3,545,065	91,746	+27.8%	Shares	Sole	2026-02-17
2025-09-30	$2,533,668	71,816	+19.6%	Shares	Sole	2025-11-14
2025-06-30	$2,164,214	60,067	+15.9%	Shares	Sole	2025-08-14
2025-03-31	$1,613,716	51,838	+29.8%	Shares	Sole	2025-05-15
2024-12-31	$1,018,716	39,934	—	Shares	Sole	2025-02-14
No filing history on record for this holder in this stock.